CLINUVEL Newsletter – March 2018

26 March 2018

The erythropoietic protoporphyria (EPP) Expert Meeting in Vienna on 16 March has had quite an impact on our global teams working in the fields of photomedicine and melanocortins. The interest in SCENESSE^® (afamelanotide 16mg)1 was high and, without exception among all delegates from 12 countries and 21 expert centres, the feedback was very positive.